Hazard
97 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 97 failed dissolution recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 5 (5%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all failed dissolution recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Strides Pharma Inc. is recalling Potassium Chloride Extended-Release Tablets, USP 10 mEq because the tablets fail to meet dissolution specifications, which may affect drug effectiveness.
Viatris is recalling Lyrica CR (pregabalin) 330 mg extended-release tablets nationwide due to failed dissolution specifications that may reduce drug effectiveness.
Akebia Therapeutics is recalling Auryxia (ferric citrate) tablets because they failed to meet dissolution specifications.
Zydus Pharmaceuticals is recalling 15,144 cartons of Lansoprazole 15 mg tablets because they failed to meet dissolution specifications.
Zydus Pharmaceuticals is recalling 22,848 cartons of Lansoprazole 30 mg tablets nationwide because they failed to meet dissolution specifications.
Torrent Pharma Inc. is recalling 2,496 bottles of Anagrelide Capsules, USP 1 mg, because the product failed to meet dissolution specifications.
Ascend Laboratories LLC is recalling 1,200 bottles of Tizanidine 4mg tablets distributed in Michigan due to failed dissolution specifications.
AvKARE Inc. is recalling specific lots of Mesalamine Delayed-Release Tablets because they failed to meet dissolution specifications.
Zydus Pharmaceuticals is recalling 7,908 cartons of Lansoprazole 30 mg tablets because they failed to meet dissolution specifications.
Zydus Pharmaceuticals is recalling 6,840 cartons of Lansoprazole 15 mg tablets because they failed to meet dissolution specifications.
Strides Inc. is recalling 11,280 bottles of Potassium Chloride Extended-Release Tablets because they failed to meet dissolution specifications.
Torrent Pharma Inc. is recalling 6,228 bottles of Carbamazepine 200 mg tablets because they failed to meet dissolution specifications.
PD-Rx Pharmaceuticals is recalling Doxycycline Hyclate 100 mg tablets because they failed to meet dissolution specifications. The recall covers 14,030 bottles distributed nationwide.
Alvogen, Inc. is recalling 2,784 bottles of Nitrofurantoin Monohydrate/Macrocrystalline capsules because they failed to meet dissolution specifications.
Alvogen, Inc. is recalling 4,272 bottles of Macrobid (nitrofurantoin monohydrate/macrocrystalline) 100 mg tablets because they failed dissolution specifications.
American Health Packaging is recalling Carbamazepine Extended-Release Tablets, 400 mg, because they failed to meet dissolution specifications.
Ascend Laboratories is recalling Atorvastatin Calcium 80 mg tablets because they failed dissolution specifications. The product was distributed to wholesalers nationwide.
UCB, Inc. is recalling 2,088 bottles of Keppra (levetiracetam) 1000 mg tablets in Tennessee due to failed dissolution specifications.
AvKARE Inc. is recalling Oxybutynin Chloride Extended-Release Tablets because they failed to meet dissolution specifications.
Amerigen Pharmaceuticals is recalling Temozolomide Capsules, 180 mg, due to failed dissolution specifications. The FDA classified this as a Class III recall.
West-Ward Columbus Inc. is recalling Doxycycline Hyclate 100 mg tablets because they failed dissolution specifications.
McKesson Packaging Services is recalling Diltiazem HCl Extended-Release Capsules because stability testing showed high dissolution results, failing specifications.
Lupin Pharmaceuticals is recalling 111,648 bottles of Duloxetine 30 mg capsules because they failed to meet dissolution standards.
Zydus Pharmaceuticals is recalling Divalproex Sodium Delayed Release Tablets because they failed to meet dissolution specifications.
Zydus Pharmaceuticals is recalling Divalproex Sodium Delayed Release Tablets because they failed to meet dissolution specifications.